These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30269155)

  • 21. Impact of 3,4-dihydroxy-6-18F-fluoro-L-phenylalanine PET/CT on managing patients with brain tumors: the referring physician's perspective.
    Walter F; Cloughesy T; Walter MA; Lai A; Nghiemphu P; Wagle N; Fueger B; Satyamurthy N; Phelps ME; Czernin J
    J Nucl Med; 2012 Mar; 53(3):393-8. PubMed ID: 22323780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact of
    Roach PJ; Francis R; Emmett L; Hsiao E; Kneebone A; Hruby G; Eade T; Nguyen QA; Thompson BD; Cusick T; McCarthy M; Tang C; Ho B; Stricker PD; Scott AM
    J Nucl Med; 2018 Jan; 59(1):82-88. PubMed ID: 28646014
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study.
    Kalff V; Hicks RJ; MacManus MP; Binns DS; McKenzie AF; Ware RE; Hogg A; Ball DL
    J Clin Oncol; 2001 Jan; 19(1):111-8. PubMed ID: 11134203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. German cardiac CT registry: indications, procedural data and clinical consequences in 7061 patients undergoing cardiac computed tomography.
    Marwan M; Achenbach S; Korosoglou G; Schmermund A; Schneider S; Bruder O; Hausleiter J; Schroeder S; Barth S; Kerber S; Leber A; Moshage W; Senges J
    Int J Cardiovasc Imaging; 2018 May; 34(5):807-819. PubMed ID: 29197025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis.
    Cacicedo J; Fernandez I; Del Hoyo O; Dolado A; Gómez-Suarez J; Hortelano E; Sancho A; Pijoan JI; Alvarez J; Espinosa JM; Gaafar A; Bilbao P
    Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1378-89. PubMed ID: 25952280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FDG-PET/CT Limited to the Thorax and Upper Abdomen for Staging and Management of Lung Cancer.
    Arens AI; Postema JW; Schreurs WM; Lafeber A; Hendrickx BW; Oyen WJ; Vogel WV
    PLoS One; 2016; 11(8):e0160539. PubMed ID: 27556809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical impact and diagnostic accuracy of 2-[
    Motara H; Olusoga T; Russell G; Jamieson S; Ahmed S; Brindle N; Pillai A; Scarsbrook AF; Patel CN; Chowdhury FU
    Clin Radiol; 2017 Jan; 72(1):63-73. PubMed ID: 27637430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
    BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-front PET/CT changes treatment intent in patients with head and neck squamous cell carcinoma.
    Rohde M; Nielsen AL; Johansen J; Sørensen JA; Diaz A; Asmussen JT; Gerke O; Thomassen A; Gyldenkerne N; Døssing H; Bjørndal K; Høilund-Carlsen PF; Godballe C
    Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):613-621. PubMed ID: 29124279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of
    Kiefer LS; Sekler J; Gückel B; Kraus MS; la Fougère C; Nikolaou K; Bitzer M; Gatidis S; Pfannenberg C
    BJR Open; 2021; 3(1):20210008. PubMed ID: 34286178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
    Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
    Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of (18)F-FDG PET/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: A prospective observational study.
    Ryu IS; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2016 Aug; 63():88-96. PubMed ID: 27288873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT.
    Gao SJ; Kim AW; Puchalski JT; Bramley K; Detterbeck FC; Boffa DJ; Decker RH
    Lung Cancer; 2017 Jul; 109():36-41. PubMed ID: 28577947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Appropriate indications for positron emission tomography/computed tomography: College of Nuclear Physicians of the Colleges of Medicine of South Africa.
    Sathekge M; Warwick JM; Doruyter A; Vorster M
    S Afr Med J; 2015 Nov; 105(11):894-6. PubMed ID: 26632309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of Brain Metastases on Follow-up
    Nia ES; Garland LL; Eshghi N; Nia BB; Avery RJ; Kuo PH
    J Nucl Med Technol; 2017 Sep; 45(3):193-197. PubMed ID: 28705927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 18F-FDG PET/CT has a high impact on patient management and provides powerful prognostic stratification in the primary staging of esophageal cancer: a prospective study with mature survival data.
    Barber TW; Duong CP; Leong T; Bressel M; Drummond EG; Hicks RJ
    J Nucl Med; 2012 Jun; 53(6):864-71. PubMed ID: 22582047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-FDG-PET/CT in the Staging and Management of Melanoma: A Prospective Multicenter Ontario PET Registry Study.
    Singnurkar A; Wang J; Joshua AM; Langer DL; Metser U
    Clin Nucl Med; 2016 Mar; 41(3):189-93. PubMed ID: 26447374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hospice Admission and Survival After
    Gareen IF; Hillner BE; Hanna L; Makineni R; Duan F; Shields AF; Subramaniam RM; Siegel BA
    J Nucl Med; 2018 Mar; 59(3):427-433. PubMed ID: 29284672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the Role of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scanning in the Staging of Patients With Stage IIIB Cervical Carcinoma and the Impact on Treatment Decisions.
    Morkel M; Ellmann A; Warwick J; Simonds H
    Int J Gynecol Cancer; 2018 Feb; 28(2):379-384. PubMed ID: 29324535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.